Dose modification in enzalutamide and abiraterone plus prednisolone for castration‐resistant prostate cancer: A subanalysis from the ENABLE study for PCa

The modified doses of ABI showed better TTPP than the standard dose of ABI and may be a potential treatment option for CRPC patients; however, its mechanism is still unclear, although its ability to suppress AR signaling is equivalent to that of a standard dose.

Authors

Institutions

Publication Details

Journal
The Prostate
Published
2024-09-20
DOI
https://doi.org/10.1002/pros.24796
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dose modification in enzalutamide and abiraterone plus prednisolone for castration‐resistant prostate cancer: A subanalysis from the ENABLE study for PCa

Takashi Shima, Yuko Yoshio, Atsushi Mizokami, Yuki Kato et al.
1 citations
The Prostate
Prostate Cancer Treatment and Research
0.42
article

Dose modification in enzalutamide and abiraterone plus prednisolone for castration‐resistant prostate cancer: A subanalysis from the ENABLE study for PCa

Takashi Shima, Yuko Yoshio, Atsushi Mizokami, Yuki Kato, Hideki Enokida, Kazuyoshi Shigehara, Kouji Izumi, Yasushi Nakai, Shizuko Takahara, Noriyasu Kawai, Nobumichi Tanaka, Seiji Hoshi, Kohei Hashimoto, Ippei Chikazawa, Shogo Inoue, Koji Mita, T. Okamura, Takashi Fukagai, Manabu Kamiyama
article en
1 citations

Abstract

The modified doses of ABI showed better TTPP than the standard dose of ABI and may be a potential treatment option for CRPC patients; however, its mechanism is still unclear, although its ability to suppress AR signaling is equivalent to that of a standard dose.

The ProstateVol. 85(1)
Kanazawa University (JP), Kagoshima University (JP), SHOWA Medical University (JP), Fukushima Medical University (JP), Sapporo Medical University (JP), Mie University (JP), Nagoya City University (JP), Toyama Prefectural Central Hospital (JP), Hiroshima City Asa Citizens Hospital (JP), University of Fukui Hospital (JP), Ishikawa Prefectural Central Hospital (JP), Fukui-ken Saiseikai Hospital (JP), Kanazawa Medical University Hospital (JP), North Medical Center (JP), Anjo Kosei Hospital (JP), Nara Medical University (JP), University of Yamanashi (JP)
Good health and well-being
Openalex Percentile: Top 33%
Prostate Cancer Treatment and Research
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.